Inhibition by antipsychotic drugs of L-type Ca2+ channel current in PC12 cells

被引:33
作者
Ito, K
Nakazawa, K
Koizumi, S
Liu, M
Takeuchi, K
Hashimoto, T
Ohno, Y
Inoue, K
机构
[1] NATL INST HLTH SCI,DIV PHARMACOL,TOKYO 158,JAPAN
[2] MEIJI COLL PHARM,DEPT PHARMACOL,TOKYO 154,JAPAN
关键词
Ca2+ channel; antipsychotic drug; dopamine receptor antagonist; calmodulin antagonist; membrane current;
D O I
10.1016/S0014-2999(96)00500-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Inhibition by antipsychotic drugs of voltage-gated L-type Ca2+ channels was characterized in rat neuronal cell line pheochromocytoma PC12 cells. Under whole-cell voltage-clamp, haloperidol and chlorpromazine (1-100 mu M) inhibited Ba2+ current permeating through Ca2+ channels. Fluspirilene and pimozide inhibited the Ba2+ current at lower concentrations (fluspirilene, 0.1 pM to 1 nM; pimozide 10 pM to 1 mu M). Effects of dopamine receptor antagonists and calmodulin antagonists were tested because antipsychotic drugs are known to exhibit these pharmacological activities. Sulpiride (1 and 10 mu M), an antagonist to dopamine D-2 receptors, and SCH-23390 (R(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine; 1 and 10 mu M), an antagonist to dopamine D-2 receptors, also inhibited the Ba2+ current. As for calmodulin antagonists, W-7(N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide; 10 and 100 mu M) as well as calmidazolium (10 nM to 1 mu M) reduced the Ba2+ current. The inhibition by haloperidol or fluspirilene of the Ba2+ current was not affected when GTP in intracellular solution was replaced with GDP beta S. These properties of the Ca2+ channel inhibition are discussed by comparing with those of the K+ channel inhibition and in relation to therapeutic relevance.
引用
收藏
页码:143 / 150
页数:8
相关论文
共 27 条
[1]   Differences between haloperidol- and pimozide-induced withdrawal syndrome: A role for Ca2+ channels [J].
AntkiewiczMichaluk, L ;
Karolewicz, B ;
Michaluk, J ;
Vetulani, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 294 (2-3) :459-467
[2]  
BEAN BP, 1989, ANNU REV PHYSIOL, V51, P367, DOI 10.1146/annurev.physiol.51.1.367
[3]  
CHOI JJ, 1992, J PHARMACOL EXP THER, V263, P49
[4]   MOLECULAR PATHOLOGY OF SCHIZOPHRENIA - MORE THAN ONE DISEASE PROCESS [J].
CROW, TJ .
BRITISH MEDICAL JOURNAL, 1980, 280 (6207) :66-68
[5]  
ENYEART JJ, 1990, J BIOL CHEM, V265, P16373
[6]  
ENYEART JJ, 1990, MOL PHARMACOL, V37, P752
[7]   HALOPERIDOL BLOCKS VOLTAGE-ACTIVATED CA2+ CHANNELS IN HIPPOCAMPAL-NEURONS [J].
FLETCHER, EJ ;
CHURCH, J ;
MACDONALD, JF .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1994, 267 (02) :249-252
[8]   DOUBLE-BLIND THERAPEUTIC EVALUATION OF FLUSPIRILENE COMPARED WITH FLUPHENAZINE DECANOATE IN CHRONIC-SCHIZOPHRENICS [J].
FRANGOS, H ;
ZISSIS, NP ;
LEONTOPOULOS, I ;
DIAMANTAS, N ;
TSITOURIDIS, S ;
GAVRIIL, I ;
TSOLIS, K .
ACTA PSYCHIATRICA SCANDINAVICA, 1978, 57 (05) :436-446
[9]   NEUROLEPTICS OF THE DIPHENYLBUTYLPIPERIDINE SERIES ARE POTENT CALCIUM-CHANNEL INHIBITORS [J].
GALIZZI, JP ;
FOSSET, M ;
ROMEY, G ;
LADURON, P ;
LAZDUNSKI, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (19) :7513-7517
[10]   R-24571 - A NEW POWERFUL INHIBITOR OF RED-BLOOD-CELL CA++-TRANSPORT ATPASE AND OF CALMODULIN-REGULATED FUNCTIONS [J].
GIETZEN, K ;
WUTHRICH, A ;
BADER, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1981, 101 (02) :418-425